Search

Your search keyword '"V. Delaney"' showing total 280 results

Search Constraints

Start Over You searched for: Author "V. Delaney" Remove constraint Author: "V. Delaney"
280 results on '"V. Delaney"'

Search Results

201. Allelic variation and environmental lead exposure in urban children.

202. Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients.

203. Medium-term outcome using sirolimus-tacrolimus combination in adult renal transplant recipients.

204. Improved lipid profile and blood sugar control in pediatric renal transplant recipients using sirolimus-tacrolimus combination.

205. Early experience using calcineurin-free protocol in recipients of high-risk cadaver renal transplants.

206. Birth to age 7 growth of children prenatally exposed to drugs: a prospective cohort study.

207. Growth from birth onwards of children prenatally exposed to drugs: a literature review.

208. Violence exposure, trauma, and IQ and/or reading deficits among urban children.

209. Development of an Instrument to Assess Problem Behavior in First Grade Students Prenatally Exposed to Cocaine. Part II: Validation.

210. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. dose-response effect.

211. Prenatal cocaine exposure as a risk factor for later developmental outcomes.

212. Neurodevelopmental outcome after congenital diaphragmatic hernia: Extracorporeal membrane oxygenation before and after surgery.

213. Expressive language development of children exposed to cocaine prenatally: literature review and report of a prospective cohort study.

214. Teacher-assessed behavior of children prenatally exposed to cocaine.

215. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994.

216. East Ireland 1980-1994: epidemiology of neural tube defects.

217. Identifying at risk infants following neonatal extracorporeal membrane oxygenation.

218. EEG abnormalities in survivors of neonatal ECMO: its role as a predictor of neurodevelopmental outcome.

219. Prenatal cocaine exposure and child behavior.

220. Prenatal coke: what's behind the smoke? Prenatal cocaine/alcohol exposure and school-age outcomes: the SCHOO-BE experience.

221. Meconium does not guarantee fetal lung maturity.

222. Renal transplantation in multiple myeloma. Case report and review of the literature.

223. Prenatal cocaine and neonatal outcome: evaluation of dose-response relationship.

224. Lung maturity tests. Relation to source, clarity, gestational age and neonatal outcome.

225. Antenatal phenobarbital therapy and neonatal outcome. II: Neurodevelopmental outcome at 36 months.

226. History of in utero cocaine exposure in language-delayed children.

227. Post extracorporeal membrane oxygenation single photon emission computed tomography (SPECT) as a predictor of neurodevelopmental outcome.

228. Prevention of hypokalemia caused by diuretics.

229. Feasibility of invasive monitoring of intracranial pressure in term neonates.

230. Mycobacterial infections in renal allograft recipients.

231. The influence of delayed renal allograft function on long-term outcome in the cyclosporine era.

232. Comparison of fine-needle aspiration biopsy, Doppler ultrasound, and radionuclide scintigraphy in the diagnosis of acute allograft dysfunction in renal transplant recipients: sensitivity, specificity, and cost analysis.

233. Iodide mumps due to low-osmolality contrast material.

234. Hyperuricemia and gout in renal allograft recipients.

235. The detrimental effect of early rejection on long-term renal allograft outcome.

236. Renal transplantation in cyclosporine-treated patients with end-stage lupus nephropathy.

237. Hydrops fetalis, polyhydramnios, pulmonary hypoplasia, and Down syndrome.

238. The course of HIV disease in renal allograft recipients.

240. The influence of nephrectomy of the primary allograft on retransplant graft outcome in the cyclosporine era.

241. Causes of late renal allograft failure in the ciclosporin era.

242. Single center experience with renal allograft sharing.

243. Renal transplantation from distant relatives.

244. Renal allograft outcome in the cyclosporine era: comparison between intermediate-term failure and long-term survival.

245. Advanced glycosylation end products in patients with diabetic nephropathy.

246. Effects of maleic acid on renal phosphorus transport: role of dietary phosphorus.

247. Retrospective analysis of posttransplantation diabetes mellitus in black renal allograft recipients.

248. Racial differences in renal transplant outcome of insulin-dependent diabetic recipients in the cyclosporine era.

249. Posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients.

250. Renal transplantation from elderly living donors.

Catalog

Books, media, physical & digital resources